Se requiere una suscripción a JoVE para ver este contenido. Inicie sesión o comience su prueba gratuita.
* These authors contributed equally
Laboratory assays can leverage prognostic value from the longitudinal optical coherence tomography (OCT)-based multimodal imaging of age-related macular degeneration (AMD). Human donor eyes with and without AMD are imaged using OCT, color, near-infrared reflectance scanning laser ophthalmoscopy, and autofluorescence at two excitation wavelengths prior to tissue sectioning.
A progression sequence for age-related macular degeneration (AMD) learned from optical coherence tomography (OCT)-based multimodal (MMI) clinical imaging could add prognostic value to laboratory findings. In this work, ex vivo OCT and MMI were applied to human donor eyes prior to retinal tissue sectioning. The eyes were recovered from non-diabetic white donors aged ≥80 years old, with a death-to-preservation time (DtoP) of ≤6 h. The globes were recovered on-site, scored with an 18 mm trephine to facilitate cornea removal, and immersed in buffered 4% paraformaldehyde. Color fundus images were acquired after anterior segment removal with a dissecting scope and an SLR camera using trans-, epi-, and flash illumination at three magnifications. The globes were placed in a buffer within a custom-designed chamber with a 60 diopter lens. They were imaged with spectral domain OCT (30° macula cube, 30 µm spacing, averaging = 25), near-infrared reflectance, 488 nm autofluorescence, and 787 nm autofluorescence. The AMD eyes showed a change in the retinal pigment epithelium (RPE), with drusen or subretinal drusenoid deposits (SDDs), with or without neovascularization, and without evidence of other causes. Between June 2016 and September 2017, 94 right eyes and 90 left eyes were recovered (DtoP: 3.9 ± 1.0 h). Of the 184 eyes, 40.2% had AMD, including early intermediate (22.8%), atrophic (7.6%), and neovascular (9.8%) AMD, and 39.7% had unremarkable maculas. Drusen, SDDs, hyper-reflective foci, atrophy, and fibrovascular scars were identified using OCT. Artifacts included tissue opacification, detachments (bacillary, retinal, RPE, choroidal), foveal cystic change, an undulating RPE, and mechanical damage. To guide the cryo-sectioning, OCT volumes were used to find the fovea and optic nerve head landmarks and specific pathologies. The ex vivo volumes were registered with the in vivo volumes by selecting the reference function for eye tracking. The ex vivo visibility of the pathology seen in vivo depends on the preservation quality. Within 16 months, 75 rapid DtoP donor eyes at all stages of AMD were recovered and staged using clinical MMI methods.
Fifteen years of managing neovascular age-related macular degeneration (AMD) with anti-VEGF therapy under the guidance of optical coherence tomography (OCT) has offered new insights into the progression sequence and microarchitecture of this prevalent cause of vision loss. A key recognition is that AMD is a three-dimensional disease involving the neurosensory retina, retinal pigment epithelium (RPE), and choroid. As a result of the OCT imaging of trial patients and the fellow eyes of treated clinic patients, the features of pathology beyond those seen by color fundus photography, a clinical standard for decades, are now recognized. These include intraretinal neovascul....
The institutional review board at the University of Alabama at Birmingham approved the laboratory studies, which adhered to Good Laboratory Practices and Biosafety Level 2/2+. All US eye banks conform to the 2006 Uniform Anatomical Gifts Act and US Food and Drug Administration. Most US eye banks, including Advancing Sight Network, conform to the medical standards of the Eye Bank Association of America.
The Table of Materials lists the supplies and equipment. Supplement.......
Table 1 shows that during 2016-2017, 184 eyes from 94 white non-diabetic donors >80 years of age were recovered. The mean death-to-preservation time was 3.9 h (range: 2.0-6.4 h). Of the 184 eyes reviewed, 75 (40.2%) had certain AMD. The following categories were identified: Unremarkable (39.7%), Questionable (11.4%), Early-Intermediate AMD (22.8%), Atrophic (7.6%), Neovascular (9.8%), Other (8.7%), and Unknown/Not Recorded/Not Gradable (<1%). Figure 2,
Using a population-based screening approach during a 16 month period in the pre-COVID era, it was possible to procure 75 donor eyes with AMD. All were recovered with a short DtoP and staged using OCT-anchored MMI. The age criterion (>80 years) is outside the typical age range for tissue recoveries intended for transplantable corneas. Despite the advanced age, our criteria resulted in eyes at all stages of AMD. Many RPE phenotypes are common to all AMD stages, and some are exclusive to neovascular AMD
We thank Heidelberg Engineering for the instrumentation and the design of the original eye holder, Richard F. Spaide MD for the introduction to OCT-based multimodal imaging, Christopher Girkin MD for facilitating access to clinical imaging devices, and David Fisher for Figure 1. The recovery of the human donor eyes for research was supported by National Institutes of Health (NIH) grants R01EY06019 (C.A.C.), P30 EY003039 (Pittler), R01EY015520 (Smith), R01EY027948 (C.A.C., T.A.) R01EY030192 (Li), R01EY031209 (Stambolian), and U54EY032442 (Spraggins), IZKF Würzburg (N-304, T.A.), the EyeSight Foundation of Alabama, the Intern....
Name | Company | Catalog Number | Comments |
Beakers, 250 mL | Fisher | # 02-540K | |
Bottles, 1 L, Pyrex | Fisher | # 10-462-719 | storage for preservative |
Bunsen burner or heat source | Eisco | # 17-12-818 | To melt wax |
Camera, digital | Nikon D7200 | D7200 | |
Computer and storage | Apple | iMac Pro; 14 TB external hard drive | Image storage |
Container, insulated | Fisher | # 02-591-45 | For wet ice |
Containers, 2 per donor, 40 mL | Fisher | Sameco Bio-Tite 40 mL # 13-711-86 | For preservative |
Crucible, quartz 30 mL | Fisher | # 08-072D | Hold globe for photography |
Cylinder, graduate, 250 mL | Fisher | # 08-549G | |
Disinfectant cleaning supplies | https://www.cardinalhealth.com/en/product-solutions/medical/infection-control/antiseptics.html | ||
Eye holder with lens and mounting bracket | contact J. Messinger | jeffreymessinger@uabmc.edu | custom modification of Heidelberg Engineering original design |
Face Protection Masks | Fisher | # 19-910-667 | |
Forceps, Harmon Fix | Roboz | # RS-8247 | |
Forceps, Micro Adson | Roboz | # RS-5232 | |
Forceps, Tissue | Roboz | # RS-5172 | |
Glass petri dish, Kimax | Fisher | # 23064 | |
Gloves Diamond Grip | Fisher | # MF-300 | |
Gowns GenPro | Fisher | # 19-166-116 | |
Image editing software | Adobe | Photoshop 2021, Creative Suite | |
KimWipes | Fisher | # 06-666 | |
Lamps, 3 goosenecks | Schott Imaging | # A20800 | |
Microscope, stereo | Nikon | SMZ 1000 | for dissection |
Microscope, stereo | Olympus | SZX9 | color fundus photography |
Paraformaldehyde, 20% | EMS | # 15713-S | for preservative; dilute for storage |
pH meter | Fisher | # 01-913-806 | |
Phosphate buffer, Sorenson’s, 0.2 M pH 7.2 | EMS | # 11600-10 | |
Ring flash | B & H Photo Video | Sigma EM-140 DG | |
Ruby bead, 1 mm diameter | Meller Optics | # MRB10MD | |
Safety Glasses 3M | Fisher | # 19-070-940 | |
Scanning laser ophthalmoscope | Heidelberg Engineering | HRA2 | |
Scissors, curved spring | Roboz | # RS-5681 | |
Sharps container | Fisher | # 1482763 | |
Shutter cord, remote | Nikon | MC-DC2 | |
Spectral Domain OCT device | Heidelberg Engineering | Spectralis HRA&OCT | https://www.heidelbergengineering.com/media/e-learning/Totara-US/files/pdf-tutorials/2238-003_Spectralis-Training-Guide.pdf |
Stainless steel ball bearing, 25.4 mm diameter | McMaster-Carr | # 9529K31 | |
Tissue marking dye, black | Cancer Diagnostics Inc | # 0727-1 | |
Tissue slicer blades | Thomas Scientific | # 6767C18 | |
Trephine, 18-mm diameter | Stratis Healthcare | # 6718L | |
TV monitor (HDMI) and cord for digital camera | B&H Photo Video | BH # COHD18G6PROB | for live viewing and remote camera display features |
Wax, pink dental | EMS | # 72670 | |
Wooden applicators | Puritan | # 807-12 |
Explore More Articles
This article has been published
Video Coming Soon
ACERCA DE JoVE
Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados